Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 19 June, 2019
KIT1,2
By
vgreene
, 19 June, 2019
BRAF1,2
By
vgreene
, 19 June, 2019
NRAS1,2
By
vgreene
, 19 June, 2019
BRAF1
By
vgreene
, 19 June, 2019
KIT1
By
vgreene
, 19 June, 2019
Cutaneous melanoma
By
vgreene
, 19 June, 2019
Metastatic dz pts
By
vgreene
, 19 June, 2019
Consider:
By
vgreene
, 19 June, 2019
ASXL11 (confirm if NCCN considers this as first-line)
By
vgreene
, 19 June, 2019
RUNX11-3 (confirm if NCCN considers this as first-line)
Pagination
First page
Previous page
…
Page
2321
Page
2322
Page
2323
Page
2324
Current page
2325
Page
2326
Page
2327
Page
2328
Page
2329
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube